Lucus Advisors’s Usana Health Sciences USNA Stock Holding History

Lucus Advisors’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$241K	Sell	2,803 -1,721	-38%	-$133K	0.42%	27
2017 Q4	$335K	Sell	4,524 -1,514	-25%	-$101K	0.49%	95
2017 Q3	$348K	Buy	+6,038	New	+$357K	0.49%	99
2017 Q2	–	Sell	-4,926	Closed	-$284K	–	260
2017 Q1	$284K	Buy	+4,926	New	+$294K	0.26%	190
2016 Q3	–	Sell	-6,308	Closed	-$351K	–	298
2016 Q2	$351K	Sell	6,308 -2,426	-28%	-$146K	0.29%	94
2016 Q1	$530K	Buy	8,734 +1,598	+22%	+$94.1K	0.31%	39
2015 Q4	$456K	Buy	7,136 +2,004	+39%	+$130K	0.28%	95
2015 Q3	$344K	Sell	5,132 -2,390	-32%	-$169K	0.19%	293
2015 Q2	$514K	Sell	7,522 -2,808	-27%	-$178K	0.25%	72
2015 Q1	$574K	Buy	10,330 +1,428	+16%	+$73.2K	0.29%	22
2014 Q4	$457K	Buy	+8,902	New	+$437K	0.2%	209

Other funds holding USNA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Lucus Advisors's USNA Position: Q1 2018 in Review

Lucus Advisors reduced its Usana Health Sciences (USNA) stake by 38% in Q1 2018, selling an estimated $133K and leaving 2,803 shares worth $241K. The position accounts for 0.42% of the portfolio, ranked #27.

Lucus Advisors first reported a position in USNA in Q4 2014 and has held it in 11 quarters since. The position peaked at $574K in Q1 2015. 168 funds tracked by Wall St. Rank hold USNA as of Q1 2018.

Lucus Advisors held 2,803 shares of Usana Health Sciences worth $241K as of Q1 2018.
Lucus Advisors sold 1,721 Usana Health Sciences shares in Q1 2018, an estimated $133K.
Usana Health Sciences made up 0.42% of Lucus Advisors's portfolio in Q1 2018, its #27 holding.
Lucus Advisors first reported a position in Usana Health Sciences in Q4 2014 and has held it in 11 quarters since.
Lucus Advisors's Usana Health Sciences position peaked at $574K in Q1 2015.
168 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2018.

Based on Lucus Advisors's 13F filing for Q1 2018, filed 15 May 2018.